Oxford Genetics signs major supply and licensing agreement for CRISPR engineered mammalian cell lines
Manus Bio Raises $19.4 million Series A Financing to Accelerate Product Commercialization and Expands Board of Directors
Ginkgo Bioworks Announces Biosecurity Initiative, Using Deep Learning to Reduce the Global Threat of Biological Weapons and Infectious Disease
Amyris Announces Signing of Major UCP in Porto/AICEP Consortium Project Agreement Valued at $50 Million
News Digest #220 – Opiates from yeast, gene editing for ag. SynBioBeta is hiring, early bird ends tomorrow.
